おかえりなさい
Click “ログイン” to agree to Cointime’s 利用規約 and acknowledge that Cointime’s プライバシーポリシー applies to you.
アカウント登録
Already have an account?
Click “page.Sign up” to agree to Cointime’s <a class="underline" href="#term-of-service">利用規約</a> and acknowledge that Cointime’s a class="underline" href="#privacy-policy">プライバシーポリシー</a> applies to you.
siteでログインする
siteで登録する
あなたのメールアドレス
受信トレイを確認する
Click the link we sent to to sign in.
Click the link we sent to to sign up.
Stargazer Pharmaceuticals
company
About
Stargazer Pharmaceuticals offers the therapy of standards disorder and manufacturer of pharmaceuticals products.
- 1 - 10
Highlights
Details
- Last Funding Type
- Series A
- Last Funding Money Raised
- $57M
- Industries
- Manufacturing,Pharmaceutical
- Founded date
- Jan 1, 2018
- Number Of Employee
- 1 - 10
- Operating Status
- Active
Stargazer Pharmaceuticals is a pharmaceutical company that offers the therapy of standards disorder and manufacturer of pharmaceuticals products. It's also a Manufacturer of pharmaceuticals. The company is currently operating in Stealth mode.
Funding Rounds
Number of Funding Rounds
Total Funding Amount
1
$57M
Stargazer Pharmaceuticals has raised a total of
$57M
in funding over 2 rounds. Their latest funding was raised on
Nov 9, 2020 from a Series A round.
| Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
|---|---|---|---|---|---|---|
| Nov 9, 2020 | Series A | $57M | 1 | — | — | Detail |
Investors
Number of Lead Investors
Number of Investors
—
1
Stargazer Pharmaceuticals is funded by 1 investors.
Retinal Degeneration Fund
are the most recent investors.
| Investor Name | Lead Investor | Funding Round |
|---|---|---|
Retinal Degeneration Fund
|
— | Series A |
Share
Twitter
LinkedIn
Line
Facebook
Telegram
Email
Page Link
